119 related articles for article (PubMed ID: 34601327)
1. In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
Ghozali N; Belguendouz H; Messaoudene D; Hadjimi Z; Ihammichene S; Chekaoui A; Benchabane S; Terahi M; Kediha I; Ali Pacha L; Touil-Boukoffa C
Int Immunopharmacol; 2021 Dec; 101(Pt A):108189. PubMed ID: 34601327
[TBL] [Abstract][Full Text] [Related]
2. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
[TBL] [Abstract][Full Text] [Related]
3. [Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease].
Ahmedi ML; Belguendouz H; Messaoudene D; Mesbah-Amroun H; Terahi M; Lahlou-Boukoffa OS; Touil-Boukoffa C
J Fr Ophtalmol; 2016 Apr; 39(4):333-40. PubMed ID: 27021132
[TBL] [Abstract][Full Text] [Related]
4. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
6. Novel effects of On-Chung-Eum, the traditional plant medicine, on cytokine production in human mononuclear cells from Behçet's.
Kim MS; Kim SO; Lim WK; Lee JM; Hwang CY; Cho KH; Kim HM
Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):65-72. PubMed ID: 12675200
[TBL] [Abstract][Full Text] [Related]
7. [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis].
Guenane H; Hartani D; Chachoua L; Lahlou-Boukoffa OS; Mazari F; Touil-Boukoffa C
J Fr Ophtalmol; 2006 Feb; 29(2):146-52. PubMed ID: 16523155
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 (IL-6) in patients with Behçet's disease.
Yamakawa Y; Sugita Y; Nagatani T; Takahashi S; Yamakawa T; Tanaka S; Nakamura S; Ohno S; Sekihara H; Okuda K; Nakajima H
J Dermatol Sci; 1996 Mar; 11(3):189-95. PubMed ID: 8785169
[TBL] [Abstract][Full Text] [Related]
9. Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis.
Yamamoto T; Sawada Y; Katayama I; Nishioka K
Br J Rheumatol; 1998 Oct; 37(10):1123-5. PubMed ID: 9825753
[TBL] [Abstract][Full Text] [Related]
10. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
[TBL] [Abstract][Full Text] [Related]
11. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
12. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
[TBL] [Abstract][Full Text] [Related]
14. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
15. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behçet's disease.
Kalayciyan A; Orawa H; Fimmel S; Perschel FH; González JB; Fitzner RG; Orfanos CE; Zouboulis CC
J Invest Dermatol; 2007 Jan; 127(1):81-9. PubMed ID: 17008886
[TBL] [Abstract][Full Text] [Related]
16. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of vitamin D supplementation on Behçet's disease patients: effect on nitric oxide and Th17/Treg cytokines production.
Oubouchou R; -Djeraba ZAA; Kemikem Y; Otmani F; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):1-10. PubMed ID: 37535442
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10.
Belguendouz H; Messaoudène D; Lahmar K; Ahmedi L; Medjeber O; Hartani D; Lahlou-Boukoffa O; Touil-Boukoffa C
J Interferon Cytokine Res; 2011 Sep; 31(9):643-51. PubMed ID: 21510811
[TBL] [Abstract][Full Text] [Related]
19. The effect of melatonin on gene expression of calcitonin gene-related peptide and some proinflammatory mediators in patients with pure menstrual migraine.
Ansari M; Karkhaneh A; Kheirollahi A; Emamgholipour S; Rafiee MH
Acta Neurol Belg; 2017 Sep; 117(3):677-685. PubMed ID: 28584969
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status in Algerian Behçet's disease patients: an immunomodulatory effect on NO pathway.
Djeraba Z; Benlabidi F; Djaballah-Ider FZ; Medjeber O; Arroul-Lammali A; Belguendouz H; Otmani F; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):243-250. PubMed ID: 28532201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
